RICHARD SANDBERG - Corporate Board Profile

Precipio, Inc.

Filing Date	Source Excerpt
2020-04-29	Richard Sandberg Director. Mr. Sandberg was elected a director of the Company on December 3, 2019. Director Summary Compensation Table: Richard Sandberg Fees Earned or Paid in Cash $1,667, Option Awards $14,480, Total $16,147.
2021-04-29	Richard Sandberg Mr. Sandberg, age 78, was appointed as director of the Company in 2019. Mr. Sandberg is a seasoned executive with a substantial track record as an executive in and a director of emerging diagnostic companies like Precipio. Mr. Sandberg founded Dianon Systems, Inc., a leading anatomic pathology laboratory based in Stratford, CT and served at various times as Chairman, Chief Executive Officer and Chief Financial Officer. He subsequently served as Chairman and Chief Financial Officer of Lifecodes Corporation, a pioneer in DNA testing technology; Chief Financial Officer and Director of Matritech Inc., a publicly traded biotechnology company specializing in proteomic diagnostic products for the early detection of a variety of cancers; and as Chief Financial Officer of Critical Diagnostics, Inc., a company specializing in developing new diagnostic tests for cardiology. More recently, Mr. Sandberg served from 2008 to June of 2019 as Chairman of Oxford Immunotec Global PLC and as a Director from 2008 until its sale to Perkin Elmer in March, 2021. Mr. Sandberg currently serves as the Chairman and Chief Executive Officer of Resolys Bio, Inc, a privately held pharmaceutical company focused on treating chronic traumatic brain injury, a position has held since September 2017. He continues to serve as chairman, director and/or executive officer of multiple privately held healthcare companies in the United States and Europe, including Poplar Healthcare LLC, a large independent anatomic pathology in Memphis, Tennessee, which entered into a joint venture with the Company in March of 2020. Mr. Sandberg earned his bachelor’s degree in Business from Northwestern University and his Master of Business Administration from Harvard Business School. Mr. Sandberg brings substantial market, operational, and financial experience to the Board which can contribute to the Company’s board decisions on strategy and execution.
2022-04-28	Richard Sandberg, Chairman Mr. Sandberg, age 79, was appointed as director of the Company in 2019 and has served as our Chairman of the Board of directors since March 2021. Mr .Sandberg is a seasoned executive with a substantial track record as an executive in and a director of emerging diagnostic companies like Precipio. In 1984 Mr. Sandberg founded Dianon Systems, Inc., a leading anatomic pathology laboratory based in Stratford, CT and served at various times as its Chairman, Chief Executive Officer and Chief Financial Officer. More recently, Mr. Sandberg served from 2008 to June of 2019 as Chairman of Oxford Immunotec Global PLC and as a Director from 2008 until its sale to PerkinElmerInc. March, 2021. Between those assignments he served as Chairman and Chief Financial Officer of Lifecodes Corporation, a pioneer in DNA testing technology; Chief Financial Officer and Director of Matritech Inc., a publicly traded biotechnology company specializing in proteomic diagnostic products for the early detection of a variety of cancers; and as Chief Financial Officer of Critical Diagnostics, Inc., a company specializing in developing new diagnostic tests for cardiology. Mr. Sandberg currently serves as the Chairman and Chief Executive Officer of Resolys Bio, Inc, a privately held pharmaceutical company focused on treating chronic traumatic brain injury, a position has held since September 2017. Mr. Sandberg brings substantial market, operational, and financial experience to the Board which can contribute to the Company’s board decisions on strategy and execution.
2023-04-25	Richard Sandberg, Chairman Mr. Sandberg, age 80, was appointed as director of the Company in 2019 and has served as our Chairman of the Board of directors since March 2021. ... The current members of the Audit Committee are directors Ms. LaPorte, the Chairperson of the Audit Committee, Dr. Fisher and Mr. Sandberg. ... Director Summary Compensation Table The following table provides information regarding our compensation for non-employee directors during the fiscal year ended December 31, 2022. ... Richard Sandberg Fees Earned or Paid in Cash ($) 75,000 Option Awards ($) 59,200 Total ($) 134,200.
2024-04-29	Richard Sandberg, Chairman Mr. Sandberg, age 81, was appointed as director of the Company in 2019 and has served as our Chairman of the Board of directors since March 2021. ... The current members of the Audit Committee are directors Ms. LaPorte, the chairperson of the Audit Committee, Mr. Sandberg and Mr. Cohen, all of whom have been determined by the Board to be independent under the Nasdaq listing standards and rules adopted by the SEC applicable to audit committee members. ... Director Summary Compensation Table The following table provides information regarding our compensation for non-employee directors during the fiscal year ended December 31, 2023. ... Richard Sandberg 75,000 Fees Earned or Paid in Cash, 17,805 Option Awards, 5,625 All Other Compensation, 98,430 Total.